Biocon Chief Says Husband's Trust Wrongly Implicated In Pandora Papers Leak
Kiran Mazumdar-Shaw on Monday said media reports on the ''Pandora Papers'' leak have wrongly implicated her husband's offshore trust, and termed the organisation as "bonafide" and "legitimate".
The industry veteran noted that both she and her husband are law abiding citizens.
Anil Ambani, Vinod Adani, Jackie Shroff, Kiran Mazumdar-Shaw, Niira Radia, Sachin Tendulkar and Satish Sharma are among the many Indians who figure in the ''Pandora Papers'' that have uncovered financial assets of leaders across the world.
"Media stories reporting on Pandora Papers wrongly implicate my husband's offshore trust, which is a bonafide, legitimate trust and is managed by Independent Trustees. No Indian resident holds “the key” to the trust as alleged in these stories," Ms Mazumdar-Shaw, the executive chairperson of biotechnology major Biocon, said in a tweet.
Media stories reporting on Pandora Papers wrongly implicate my husband's offshore trust, which is a bonafide, legitimate trust and is managed by Independent Trustees. No Indian resident holds “the key” to the trust as alleged in these stories.
October 4, 2021Later, in a regulatory filing, she elaborated on the offshore trusts.
"My husband, John Shaw is a UK national who from his foreign currency earnings set up an investment company, Glentec International in 1999 to acquire the shares that Unilever Plc. held in Biocon (long before it became a publicly listed company) and for various other investments in real estate and public markets," Ms Mazumdar-Shaw stated.
Glentec is a registered entity in Mauritius disclosed to both RBI and SEBI, she added.
"When Biocon went public in 2004, Glentec's shareholding in Biocon was disclosed and this information continues to be in public domain. Glentec holds 19.76 per cent of Biocon Limited as per latest disclosures to the stock exchanges," she noted.
She further stated Glentec is a bonafide offshore company (99 per cent owned by John Shaw) whose income from India largely consists of tax paid dividends received from Biocon Limited.
John Shaw's tax returns filed in India report his shareholding and directorship in Glentec, she added.
Besides, Glentec is audited as per statutes and full disclosure of its dividend income from Indian companies is made, Ms Mazumdar-Shaw said.
Commenting on Deanstone Trust, she noted that it was set up by Glentec in 2015 to enable philanthropic endowments and for the purpose of estate planning for both John Shaw and her family members.
"This is a bonafide offshore trust managed by Independent Trustees who are foreign nationals, not resident in India," she said, adding that Glentec is the sole settlor of the Deanstone Trust.
Ms Mazumdar-Shaw further said, "both John Shaw and I are neither trustees, nor settlors, nor beneficiaries of this trust. Beneficiaries of this trust, who are family members, are foreign nationals and not resident Indians."
Philanthropic beneficiaries of the trust are mainly academic institutions and contributions or endowments made to them are all in the public domain, she stated.
"These are completely baseless accusations. Both John Shaw and I are law abiding citizens and have always been in compliance with all the applicable regulations," Ms Mazumdar-Shaw added.
-
Signature Play: The Classic Cocktail Is Dead. Or Is It?
Classic cocktails are disappearing from India's cocktail menus. But they're still being ordered, taught to bartenders and borrowed from. So, who's really having the last drink?
-
A New Samvat Wishlist: Inclusive Prosperity And Human Development
India has strengthened its economic foundations through infrastructure, digital access and enterprise. Its next growth chapter must deepen productivity, create better livelihoods and widen participation in prosperity.
-
Love, Sex Aur Dhokha: The Audacious Plot To Spy On Jensen Huang
A Taipei dinner, a Singapore chip buyer and a suspected Chinese asset: inside the alleged spy operation that got close to NVIDIA's Jensen Huang.
-
Ten Things I Learnt This Samvat
Patience can be a trap. Cheap stocks can stay cheap. Leverage can wipe you out. What did Samvat 2082 teach us? Niraj Shah writes on 10 lessons from the year gone by.
-
Talking Points This Week: Tech Nerves, FII Buying, And A Faraway Banking Shock
The global markets are not shining this Diwali. The exception in the large markets is, India.
-
Midterm Rally Lasted A Day. The Hard Reality Of A Divided US May Last Two Years | Opinion
Between a contested AI boom, a debt ceiling that arrives in 2027 and a president with every incentive to act alone, the next two years may prove more volatile than the first day's rally suggests.
-
Blue Wave Will Derail the AI Trade but Won't Dismantle the AI Era | Unhedged Position
The Democrats' sweep of the US Congress will see politics collide with economic forces both over the long and short term.
-
It's Time To Take The GST Council's Bet On Trust Global
Payment records can prove India's services exports, and clear, proportionate rules can bring foreign digital sellers into the tax net.
-
Opinion | India at 38: From Innovation Overperformer to Innovation Powerhouse
India now has 453 VC-backed deep science startups, 18 of them late-stage, after 117 percent growth since 2020. Laurus Labs, at USD 9.3 billion, is the most valuable deep science company in any middle-income economy outside China.
